Lisa Johnson-Pratt
Director/Board Member at TRACON PHARMACEUTICALS, INC.
Net worth: - $ as of 2017-12-30
Profile
Lisa R.
Johnson-Pratt is currently serving as an Independent Director at TRACON Pharmaceuticals, Inc., Assembly Biosciences, Inc., and Director at Internet Sciences, Inc. She is also a Director at Young People in Recovery.
Previously, she worked as Global Marketing Director at Stiefel Laboratories, Inc. from 2013 to 2015, Senior Vice President-New Product Planning at Ionis Pharmaceuticals, Inc., and Head-Global Pharma Commercial Operations at GSK Plc from 2013 to 2019.
In 2020, she served as Senior Vice President-New Product Strategy at Akcea Therapeutics, Inc. Dr. Johnson-Pratt completed her undergraduate and doctorate degrees from Howard University.
Known holdings in public companies
| Company | Date | Number of shares | Valuation | Valuation date |
|---|---|---|---|---|
Internet Sciences, Inc.
 Internet Sciences, Inc. Advertising/Marketing ServicesCommercial Services Internet Sciences, Inc. operates as an information and communications technology company. It specializes in digital telecommunication, data center and co-location, and media IoT. The company was founded by Lynda Chervil in 2016 and is headquartered in New York, NY. 0.07% | 2023-11-19 | 13,500 ( 0.07% ) | 0 $ | 2017-12-30 |
| 2023-12-07 | 0 ( -.--% ) | - $ | 2024-03-30 | |
| 2024-02-14 | 0 ( -.--% ) | - $ | 2024-03-30 |
Lisa Johnson-Pratt active positions
| Companies | Position | Start |
|---|---|---|
| TRACON PHARMACEUTICALS, INC. | Director/Board Member | 2021-03-01 |
| ASSEMBLY BIOSCIENCES, INC. | Director/Board Member | 2021-05-19 |
| Young People in Recovery | Director/Board Member | - |
Internet Sciences, Inc.
Internet Sciences, Inc. Advertising/Marketing ServicesCommercial Services Internet Sciences, Inc. operates as an information and communications technology company. It specializes in digital telecommunication, data center and co-location, and media IoT. The company was founded by Lynda Chervil in 2016 and is headquartered in New York, NY. | Director/Board Member | 2022-12-30 |
Former positions of Lisa Johnson-Pratt
| Companies | Position | End |
|---|---|---|
| AKCEA THERAPEUTICS, INC. | Corporate Officer/Principal | 2020-10-31 |
| GSK PLC | Corporate Officer/Principal | 2019-06-30 |
Stiefel Laboratories, Inc.
 Stiefel Laboratories, Inc. Pharmaceuticals: MajorHealth Technology Stiefel Laboratories, Inc. engages in the manufacture of pharmaceutical products. It offers prescription and non-prescription dermatological and skin care products. The firm research, innovate and develop skin care treatments to health care professionals, patients and consumers. The company was founded in 1847 and is headquartered in Research Triangle Park, NC. | Sales & Marketing | 2014-12-31 |
| IONIS PHARMACEUTICALS, INC. | Corporate Officer/Principal | - |
Training of Lisa Johnson-Pratt
| Howard University | Doctorate Degree |
Experiences
Positions held
Connections
1st degree connections
1st degree companies
Male
Female
Members of the board
Executives
Linked companies
| Listed companies | 4 |
|---|---|
| IONIS PHARMACEUTICALS, INC. | Health Technology |
| TRACON PHARMACEUTICALS, INC. | Health Technology |
| GSK PLC | Health Technology |
| ASSEMBLY BIOSCIENCES, INC. | Health Technology |
| Private companies | 4 |
|---|---|
Stiefel Laboratories, Inc.
Stiefel Laboratories, Inc. Pharmaceuticals: MajorHealth Technology Stiefel Laboratories, Inc. engages in the manufacture of pharmaceutical products. It offers prescription and non-prescription dermatological and skin care products. The firm research, innovate and develop skin care treatments to health care professionals, patients and consumers. The company was founded in 1847 and is headquartered in Research Triangle Park, NC. | Health Technology |
Akcea Therapeutics, Inc.
 Akcea Therapeutics, Inc. Pharmaceuticals: MajorHealth Technology Akcea Therapeutics, Inc. is a biopharmaceutical company. It engages in the development and marketing of drugs globally to treat patients with rare and serious diseases using antisense technology. Its primary focus is developing TEGSEDI, a therapy that treats the polyneuropathy caused by hereditary transthyretin-mediated amyloidosis in adults. It also offers a mature pipeline of novel drugs including AKCEA-APO(a)-LRx, AKCEA-ANGPTL3-LRx, and AKCEA-APOCIII-LRx. The company was founded in December 2014 and is headquartered in Cambridge, MA. | Health Technology |
Internet Sciences, Inc.
Internet Sciences, Inc. Advertising/Marketing ServicesCommercial Services Internet Sciences, Inc. operates as an information and communications technology company. It specializes in digital telecommunication, data center and co-location, and media IoT. The company was founded by Lynda Chervil in 2016 and is headquartered in New York, NY. | Commercial Services |
| Young People in Recovery |
- Stock Market
- Insiders
- Lisa Johnson-Pratt
